Advertisement

Familial Cancer

, Volume 14, Issue 2, pp 265–272 | Cite as

Health professionals’ evaluation of delivering treatment-focused genetic testing to women newly diagnosed with breast cancer

  • Kirsten F. L. Douma
  • Bettina Meiser
  • Judy Kirk
  • Gillian Mitchell
  • Christobel Saunders
  • Belinda Rahman
  • Mariana S. Sousa
  • Kristine Barlow-Stewart
  • Margaret Gleeson
  • Kathy Tucker
Original Article

Abstract

Increasingly, women are offered genetic testing shortly after diagnosis of breast cancer to facilitate decision-making about treatment, often referred to as ‘treatment-focused genetic testing’ (TFGT). As understanding the attitudes of health professionals is likely to inform its integration into clinical care we surveyed professionals who participated in our TFGT randomized control study. Thirty-six completed surveys were received (response rate 59 %), 15 (42 %) health professionals classified as genetic and 21 (58 %) as non-genetic. Mainly positive experiences with participating in the TFGT trial were reported. The high cost of testing and who could best deliver information about TGFT to the patient were raised as key constraints to implementation of TFGT in usual care. More non-genetic than genetic health professionals (44 vs 8 %) preferred that the surgeon provide the information for decision-making about TFGT. While costs of TFGT itself and the time and effort of staff involved were perceived barriers, as testing costs become lower, it is expected that TFGT will become a routine part of standard clinical care for patients at high genetic risk in the near future.

Keywords

Oncology professionals Attitudes Genetic testing Breast cancer Diagnosis Treatment-focused genetic testing Rapid genetic counseling 

Notes

Acknowledgments

This study was funded as part of a Priority-Driven Collaborative Research Scheme grant that was jointly supported by Cancer Australia, Cancer Council and the National Breast Cancer Foundation (ID 630405). Bettina Meiser is supported by a Career Development Fellowship Award from the National Health and Medical Research Council Australia and a Cancer Institute New South Wales Career Development Fellowship. Kirsten Douma is supported by a Fellowship Award from the Dutch Cancer Society (UVA 2011-4918). We thank the health professionals who participated in this study. We gratefully acknowledge the support and endorsement of the Psycho-oncology Cooperative Research Group (PoCoG) for this project.

Conflict of interest

No conflict of interest are reported.

Supplementary material

10689_2014_9770_MOESM1_ESM.pdf (108 kb)
Supplementary material 1 (PDF 107 kb)

References

  1. 1.
    Ardern-Jones A, Kenen R, Eeles R (2005) Too much, too soon? Patients and health professionals’ views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40. Eur J Cancer Care (Engl) 14(3):272–281CrossRefGoogle Scholar
  2. 2.
    Van Riel RE, Warlam-Rodenhuis CC, Verhoef S, Rutgers EJ, Ausems MG (2010) BRCA testing of breast cancer patients: medical specialists’ referral patterns, knowledge and attitudes to genetic testing. Eur J Cancer Care (Engl) 19(3):369–376CrossRefGoogle Scholar
  3. 3.
    Schwartz MD, Lerman C, Brogan B, Peshkin BN, Halbert CH, DeMarco T et al (2004) Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients. J Clin Oncol 22(10):1823–1829CrossRefPubMedGoogle Scholar
  4. 4.
    Meiser B, Tucker K, Friedlander M, Barlow-Stewart K, Lobb E, Saunders C et al (2008) Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda. Breast Cancer Res 10(6):216CrossRefPubMedCentralPubMedGoogle Scholar
  5. 5.
    Silva E (2008) Genetic counseling and clinical management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations: perspective of a surgical oncologist. Fam Cancer 7(1):91–95CrossRefPubMedGoogle Scholar
  6. 6.
    Lobb EA, Barlow-Stewart K, Suthers G, Hallowell N (2010) Treatment-focused DNA testing for newly diagnosed breast cancer patients: some implications for clinical practice. Clin Genet 77(4):350–354CrossRefPubMedGoogle Scholar
  7. 7.
    Hartmann LC, Sellers TA, Schaid DJ, Frank TS, Soderberg CL, Sitta DL et al (2001) Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 93(21):1633–1637CrossRefPubMedGoogle Scholar
  8. 8.
    Wevers MR, Aaronson NK, Verhoef S, Bleiker EM, Hahn DE, Kuenen MA et al (2014) Impact of rapid genetic counselling and testing on the decision to undergo immediate or delayed prophylactic mastectomy in newly diagnosed breast cancer patients: findings from a randomised controlled trial. Br J Cancer 110(4):1081–1087CrossRefPubMedCentralPubMedGoogle Scholar
  9. 9.
    Meiser B, Gleeson M, Kasparian N, Barlow-Stewart K, Ryan M, Watts K et al (2012) There is no decision to make: experiences and attitudes toward treatment-focused genetic testing among women diagnosed with ovarian cancer. Gynecol Oncol 124(1):153–157CrossRefPubMedGoogle Scholar
  10. 10.
    Zilliacus E, Meiser B, Gleeson M, Watts K, Tucker K, Lobb EA et al (2012) Are we being overly cautious? A qualitative inquiry into the experiences and perceptions of treatment-focused germline BRCA genetic testing amongst women recently diagnosed with breast cancer. Support Care Cancer 20(11):2949–2958CrossRefPubMedGoogle Scholar
  11. 11.
    Meiser B, Gleeson M, Watts K, Peate M, Zilliacus E, Barlow-Stewart K et al (2012) Getting to the point: what women newly diagnosed with breast cancer want to know about treatment-focused genetic testing. Oncol Nurs Forum 39(2):E101–E111CrossRefPubMedGoogle Scholar
  12. 12.
    Escher M, Sappino AP (2000) Primary care physicians’ knowledge and attitudes towards genetic testing for breast-ovarian cancer predisposition. Ann Oncol 11(9):1131–1135CrossRefPubMedGoogle Scholar
  13. 13.
    Burcher S, Meiser B, Mitchell G, Saunders C, Rahman B, Tucker K et al (2013) Oncology health professionals’ attitudes toward treatment-focused genetic testing for women newly diagnosed with breast cancer. Personal Med 10(5):431–440CrossRefGoogle Scholar
  14. 14.
    Watts KJ, Meiser B, Mitchell G, Kirk J, Saunders C, Peate M et al (2012) How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer. BMC Cancer 12:320CrossRefPubMedCentralPubMedGoogle Scholar
  15. 15.
    Hondow HL, Fox SB, Mitchell G, Scott RJ, Beshay V, Wong SQ et al (2011) A high-throughput protocol for mutation scanning of the BRCA1 and BRCA2 genes. BMC Cancer 11:265CrossRefPubMedCentralPubMedGoogle Scholar
  16. 16.
    Gleeson M, Meiser B, Barlow-Stewart K, Trainer AH, Tucker K, Watts KJ et al (2013) Communication and information needs of women diagnosed with ovarian cancer regarding treatment-focused genetic testing. Oncol Nurs Forum 40(3):275–283CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2014

Authors and Affiliations

  • Kirsten F. L. Douma
    • 1
  • Bettina Meiser
    • 2
  • Judy Kirk
    • 3
  • Gillian Mitchell
    • 4
    • 5
  • Christobel Saunders
    • 6
  • Belinda Rahman
    • 2
  • Mariana S. Sousa
    • 2
  • Kristine Barlow-Stewart
    • 7
  • Margaret Gleeson
    • 8
  • Kathy Tucker
    • 9
  1. 1.Department of Medical Psychology, Academic Medical CenterUniversity of AmsterdamAmsterdamThe Netherlands
  2. 2.Psychosocial Research Group, Lowy Cancer Research Centre C25, Prince of Wales Clinical SchoolUniversity of New South Wales AustraliaSydneyAustralia
  3. 3.Familial Cancer Service, Westmead Institute for Cancer Research, Westmead Millenium InstituteUniversity of SydneySydneyAustralia
  4. 4.Familial Cancer Centre, Peter MacCallum Cancer CentreMelbourneAustralia
  5. 5.Sir Peter MacCallum Department of OncologyThe University of MelbourneMelbourneAustralia
  6. 6.School of SurgeryUniversity of Western AustraliaCrawleyAustralia
  7. 7.Sydney Medical SchoolSydney UniversitySydneyAustralia
  8. 8.Hunter Family Cancer ServiceNewcastleAustralia
  9. 9.Hereditary Cancer Clinic, Prince of Wales HospitalRandwick, SydneyAustralia

Personalised recommendations